Trump's tariff threat takes the sheen off Lupin’s product launches
A big dampener to Lupin’s plans would be the potential imposition of tariff on pharma products by the Trump government.
Lupin shares rise nearly 3% on launch of Rivaroxaban Tablets USP, in the US
Lupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over ...
This Harry Potter Movie Is Still the Best One (And It’s Secretly a Horror Film)
Harry Potter went down in history as a landmark in literature and cinema, winning a legion of loyal fans to this day. But ...
Lupin launches Rivaroxaban drug in US
Lupin announced that it has launched Rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug ...
Anil Singhvi's Big Call: Is Lupin a Buy Now?
Buy Lupin Futures, SL 2000 Tgt 2050, 2070, Generic heart disease drug 'Rivaroxaban' launched in US, Nomura maintains Buy ...
Medpage Today on MSN7d
First Generics for Low-Dose Rivaroxaban Get FDA Approval
The FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday.
Meet the cast of The Au Pair on Channel 5
However, things start to unravel for Zoe as she deals with mounting pressure, work mishaps and personal problems. As well as ...
Lupin Consolidated December 2024 Net Sales at Rs 5,767.71 crore, up 10.97% Y-o-Y
Quarterly Net Profit at Rs. 855.16 crore in December 2024 up 39.48% from Rs. 613.12 crore in December 2023. EBITDA stands at ...
CNBCTV185d
Lupin launches generic heart drug rivaroxaban in US
This follows the final approval from the US FDA for its abbreviated new drug application (ANDA). Shares of Lupin Ltd ended at ...